Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Wurster I" with an ORCID

Isabel Wurster
No affiliation detected
2
Publications
3,671
Citations
View profile

Search results

1-25 of 81 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants.
Lerche S, Wurster I, Valente EM, Avenali M, Samaniego D, Martínez-Vicente M, Hernández-Vara J, Laguna A, Sturchio A, Svenningsson P, France NP, Barlow C, Sankaranarayanan S, Brockmann K
NPJ Parkinsons Dis, 10(1):198, 24 Oct 2024
Cited by: 0 articles | PMID: 39448669 | PMCID: PMC11502890
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants.
Schalkamp AK, Lerche S, Wurster I, Roeben B, Zimmermann M, Fries F, von Thaler AK, Eschweiler G, Maetzler W, Berg D, Sinz FH, Brockmann K
Front Aging Neurosci, 16:1447944, 15 Oct 2024
Cited by: 0 articles | PMID: 39474283 | PMCID: PMC11518739
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CSF Sphingolipids in Parkinson Disease and Dementia with Lewy Bodies with and without GBA1 variants
Brockmann K, Lerche S, Wurster I, Valente EM, Avenali M, Samaniego D, Martinez-Vicente M, Hernandez-Vara J, Laguna A, Sturchio A, Svenningsson P, France N, Barlow C, Sankaranarayanan S
Research Square, 18 Jul 2024
Cited by: 0 articles | PPR: PPR883542
Add to export list Preprint v1
Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.
Zimmermann M, Fandrich M, Jakobi M, Röben B, Wurster I, Lerche S, Schulte C, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Gasser T, Brockmann K
Eur J Neurol, 31(10):e16388, 01 Jul 2024
Cited by: 1 article | PMID: 38946703 | PMCID: PMC11414814
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.
Roeben B, Liepelt-Scarfone I, Lerche S, Zimmermann M, Wurster I, Sünkel U, Schulte C, Deuschle C, Eschweiler GW, Maetzler W, Gasser T, Berg D, Brockmann K
NPJ Parkinsons Dis, 10(1):88, 22 Apr 2024
Cited by: 2 articles | PMID: 38649346 | PMCID: PMC11035543
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis.
Ye L, Greten S, Wegner F, Doll-Lee J, Krey L, Heine J, Gandor F, Vogel A, Berger L, Gruber D, Levin J, Katzdobler S, Peters O, Dashti E, Priller J, Spruth EJ, Kühn AA, Krause P, Spottke A, [...] Klietz M
J Neurol, 271(5):2639-2648, 14 Feb 2024
Cited by: 2 articles | PMID: 38353748 | PMCID: PMC11055732
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C, Roeben B, Mammana A, Zimmermann M, Hauser AK, Deuschle C, Schulte C, Liepelt-Scarfone I, Gasser T, Parchi P
NPJ Parkinsons Dis, 10(1):24, 20 Jan 2024
Cited by: 3 articles | PMID: 38242875 | PMCID: PMC10799016
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association of high alpha-Klotho-levels in CSF with a later onset of cognitive impairment in patients with Parkinson´s disease
Zimmermann M, Fandrich M, Jakobi M, Schulte C, Roeben B, Wurster I, Lerche S, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Gasser T, Brockmann K
Research Square, 17 Jan 2024
Cited by: 0 articles | PPR: PPR788817
Add to export list Preprint v1
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.
Zimmermann M, Fandrich M, Jakobi M, Röben B, Wurster I, Lerche S, Schulte C, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Joos TO, Gasser T, Brockmann K
J Parkinsons Dis, 14(7):1405-1416, 01 Jan 2024
Cited by: 0 articles | PMID: 39240648 | PMCID: PMC11492048
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in PD
Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C, Roeben B, Mammana A, Zimmermann M, Hauser A, Deuschle C, Schulte C, Liepelt-Scarfone I, Gasser T, Parchi P
Research Square, 26 Jul 2023
Cited by: 0 articles | PPR: PPR697944
Add to export list Preprint v1
Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.
Koros C, Brockmann K, Simitsi AM, Bougea A, Liu H, Hauser AK, Schulte C, Lerche S, Pachi I, Papagiannakis N, Antonelou R, Zahou A, Wurster I, Efthymiopoulou E, Beratis I, Maniati M, Moraitou M, Michelakakis H, Paraskevas G, [...] Stefanis L
Mov Disord, 38(5):907-909, 06 May 2023
Cited by: 1 article | PMID: 37148559
Add to export list
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly
Schalkamp A, Lerche S, Wurster I, Roeben B, Zimmermann M, Fries F, Thaler A, Eschweiler G, Gasser T, Maetzler W, Berg D, Brockmann K, Sinz F
Research Square, 08 May 2023
Cited by: 0 articles | PPR: PPR656956
Add to export list Preprint v1
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.
Lerche S, Zimmermann M, Roeben B, Wurster I, Fries FL, Deuschle C, Waniek K, Lachmann I, Jakobi M, Joos TO, Knorpp T, Schneiderhan-Marra N, Brockmann K
NPJ Parkinsons Dis, 9(1):38, 11 Mar 2023
Cited by: 6 articles | PMID: 36906614 | PMCID: PMC10008539
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study.
Rattay TW, Völker M, Rautenberg M, Kessler C, Wurster I, Winter N, Haack TB, Lindig T, Hengel H, Synofzik M, Schüle R, Martus P, Schöls L
Brain, 146(3):1093-1102, 01 Mar 2023
Cited by: 3 articles | PMID: 35472722
Add to export list
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Brüggemann N, Borsche M, Foroud T, [...] MJFF Global Genetic Parkinson's Disease Study Group
Mov Disord, 38(2):286-303, 24 Jan 2023
Cited by: 14 articles | PMID: 36692014
Add to export list
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly
Schalkamp A, Lerche S, Wurster I, Roeben B, Zimmermann M, Fries F, von Thaler A, Eschweiler G, Gasser T, Maetzler W, Berg D, Brockmann K, Sinz FH
medRxiv, 18 Nov 2022
Cited by: 0 articles | PPR: PPR573004
Add to export list Preprint
SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson's Disease Patients.
Zafar S, Noor A, Younas N, Shafiq M, Schmitz M, Wurster I, Brockmann K, Gasser T, Zerr I
Int J Mol Sci, 23(22):14166, 16 Nov 2022
Cited by: 2 articles | PMID: 36430645 | PMCID: PMC9699576
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact ofAPOEgenotype on cognition in idiopathic and genetic forms of Parkinson’s disease
Koros C, Brockmann K, Simitsi A, Bougea A, Liu H, Hauser A, Schulte C, Lerche S, Pachi I, Papagiannakis N, Antonelou R, Zahou A, Wurster I, Efthymiopoulou E, Beratis I, Maniati M, Moraitou M, Michelakakis H, Paraskevas G, [...] Stefanis L
medRxiv, 10 Nov 2022
Cited by: 0 articles | PPR: PPR569814
Add to export list Preprint
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
Brockmann K, Lerche S, Zimmermann M, Roeben B, Wurster I, Fries F, Deuschle C, Waniek K, Lachmann I, Jakobi M, Joos T, Schneiderhan-Marra N, Knorpp T
Research Square, 11 Oct 2022
Cited by: 0 articles | PPR: PPR556700
Add to export list Preprint v1
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding.
Wurster I, Quadalti C, Rossi M, Hauser AK, Deuschle C, Schulte C, Waniek K, Lachmann I, la Fougere C, Doppler K, Gasser T, Bender B, Parchi P, Brockmann K
NPJ Parkinsons Dis, 8(1):117, 15 Sep 2022
Cited by: 8 articles | PMID: 36109514 | PMCID: PMC9476413
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, [...] Prasinezumab Study Group
N Engl J Med, 387(5):421-432, 01 Aug 2022
Cited by: 101 articles | PMID: 35921451
Add to export list
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers.
Lerche S, Zimmermann M, Wurster I, Roeben B, Fries FL, Deuschle C, Waniek K, Lachmann I, Gasser T, Jakobi M, Joos TO, Schneiderhan-Marra N, Brockmann K
Front Neurol, 13:834580, 25 Feb 2022
Cited by: 12 articles | PMID: 35280273 | PMCID: PMC8914943
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
Jackson H, Anzures-Cabrera J, Taylor KI, Pagano G, PASADENA Investigators, Prasinezumab Study Group
Front Neurosci, 15:765765, 13 Dec 2021
Cited by: 4 articles | PMID: 34966256 | PMCID: PMC8711238
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
Brockmann K, Quadalti C, Lerche S, Rossi M, Wurster I, Baiardi S, Roeben B, Mammana A, Zimmermann M, Hauser AK, Deuschle C, Schulte C, Waniek K, Lachmann I, Sjödin S, Brinkmalm A, Blennow K, Zetterberg H, Gasser T, Parchi P
Acta Neuropathol Commun, 9(1):175, 30 Oct 2021
Cited by: 38 articles | PMID: 34717775 | PMCID: PMC8556894
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, [...] Prasinezumab Study Group
Front Neurol, 12:705407, 01 Oct 2021
Cited by: 36 articles | PMID: 34659081 | PMCID: PMC8518716
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 81 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Wurster I" with an ORCID

Search results

CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants.

Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants.

CSF Sphingolipids in Parkinson Disease and Dementia with Lewy Bodies with and without GBA1 variants

Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.

Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.

The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis.

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.

Association of high alpha-Klotho-levels in CSF with a later onset of cognitive impairment in patients with Parkinson´s disease

Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in PD

Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.

Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.

The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study.

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.

Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderly

SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson's Disease Patients.

Impact ofAPOEgenotype on cognition in idiopathic and genetic forms of Parkinson’s disease

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding.

Trial of Prasinezumab in Early-Stage Parkinson's Disease.

CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers.

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Wurster I" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Wurster I" with an ORCID